| All study participants | NAFLD patients | ||||||
---|---|---|---|---|---|---|---|---|
All NAFLD | Lean NAFLD | Obese NAFLD | ||||||
 | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P |
Model 1 | Â | 0.001 | Â | 0.096 | Â | 0.754 | Â | 0.048 |
GG | 1 | 1 | 1 | 1 | ||||
AA + AG | 1.130 (1.053–1.213) | 1.162 (0.974–1.387) | 0.899 (0.467–1.750) | 1.526 (1.004–2.319) | ||||
Model 2 | Â | 0.002 | Â | 0.133 | Â | 0.721 | Â | 0.055 |
GG | 1 | 1 | 1 | 1 | ||||
AA + AG | 1.120 (1.043–1.203) | 1.151 (0.958–1.382) | 0.886 (0.455–1.723) | 1.504 (0.991–2.282) |